Encephalitis lethargica

Changed by Rohit Sharma, 18 Feb 2018

Updates to Article Attributes

Body was changed:

Encephalitis lethargica (EL) is a rare disease that is also, also known as von Economo encephalitis. It, is a rare disease of unknown aetiology that affects the midbrain and basal ganglia, and the exact aetiology is unknown

Clinical presentation

Symptoms are initially that of pharyngitis followed by lethargy, extrapyramidal movements (parkinsonism and dyskinesias), neuropsychiatricdisturbance (obsessive, compulsive disorder, catatonia, mutism, apathy and conduct disorders), and ocular movement disorder (oculogyric crises).

Pathology

The exact aetiology is unknown, but there is lymphocyte infiltration of the midbrain and basal ganglia. It is thought that there may be an autoimmune component, possibly triggered after a viral infection.

Markers

Autoantibodies reactive against human basal ganglia antigens present in the majority of ELencephalitis lethargica patients. 

Radiographic features

MRI

Brain MRI demonstrates inflammatory changes localised to the deep grey matterin 40% of patients.

  • T1: low signal
  • T2/FLAIR: high signal in the basal ganglia (including the substantia nigra), midbrain, thalamus, cerebral peduncle and/or temporal cortex
  • T1 C+ (Gd): leptomeningeal and focal patchy enhancement 
  • DWI/ADC: isointense without restriction of ADC
Nuclear medicine
  • PET-CT:increased glucose metabolism in the basal ganglia

Treatment and prognosis

Treatment approaches to encephalitis lethargica include immunomodulating therapies and steroids.

History and etymology

First described by Constantin Freiherr von Economo in (1876-1931), a Romanian psychiatrist and neurologist, in 1916 during an epidemic affecting 500,000 people worldwide in 1916-19274. There have been no further epidemics of ELencephalitis lethargica since the 1920s, although sporadic cases have continued to be reported.

Differential diagnosis

General imaging differential considerations include:

  • -<p><strong>Encephalitis lethargica</strong> (<strong>EL</strong>) is a rare disease that is also known as <strong>von Economo encephalitis</strong>. It affects the midbrain and basal ganglia, and the exact aetiology is unknown. </p><h4>Clinical presentation</h4><p>Symptoms are initially that of pharyngitis followed by lethargy, extrapyramidal movements (parkinsonism and dyskinesias), neuropsychiatric<br>disturbance (obsessive, compulsive disorder, catatonia, mutism, apathy and conduct disorders), and ocular movement disorder (oculogyric crises).</p><h4>Pathology</h4><p>The exact aetiology is unknown, but there is lymphocyte infiltration of the midbrain and basal ganglia.</p><h5>Markers</h5><p>Autoantibodies reactive against human basal ganglia antigens present in the majority of EL patients. </p><h4>Radiographic features</h4><h5>MRI</h5><p>Brain MRI demonstrates inflammatory changes localised to the deep grey matter<br>in 40% of patients.</p><ul>
  • +<p><strong>Encephalitis lethargica</strong>, also known as <strong>von Economo encephalitis</strong>, is a rare disease of unknown aetiology that affects the <a href="/articles/midbrain">midbrain</a> and <a href="/articles/basal-ganglia">basal ganglia</a>. </p><h4>Clinical presentation</h4><p>Symptoms are initially that of pharyngitis followed by lethargy, extrapyramidal movements (parkinsonism and dyskinesias), neuropsychiatric<br>disturbance (obsessive, compulsive disorder, catatonia, mutism, apathy and conduct disorders), and ocular movement disorder (oculogyric crises).</p><h4>Pathology</h4><p>The exact aetiology is unknown, but there is lymphocyte infiltration of the midbrain and basal ganglia. It is thought that there may be an autoimmune component, possibly triggered after a viral infection.</p><h5>Markers</h5><p>Autoantibodies reactive against human basal ganglia antigens present in the majority of encephalitis lethargica patients. </p><h4>Radiographic features</h4><h5>MRI</h5><p>Brain MRI demonstrates inflammatory changes localised to the deep grey matter<br>in 40% of patients.</p><ul>
  • -</ul><h5>Nuclear medicine</h5><ul><li>PET-CT:<strong> </strong>increased glucose metabolism in the basal ganglia</li></ul><h4>Treatment and prognosis</h4><p>Treatment approaches to encephalitis lethargica include immunomodulating therapies and steroids.</p><h4>History and etymology</h4><p>First described by <strong>von Economo</strong> in 1916 during an epidemic affecting 500,000 people worldwide in 1916-1927. There have been no further epidemics of EL since the 1920s, although sporadic cases have continued to be reported.</p><h4>Differential diagnosis</h4><p>General imaging differential considerations include:</p><ul>
  • +</ul><h5>Nuclear medicine</h5><ul><li>PET-CT:<strong> </strong>increased glucose metabolism in the basal ganglia</li></ul><h4>Treatment and prognosis</h4><p>Treatment approaches to encephalitis lethargica include immunomodulating therapies and steroids.</p><h4>History and etymology</h4><p>First described by <strong>Constantin Freiherr von Economo</strong> (1876-1931), a Romanian psychiatrist and neurologist, in 1916 during an epidemic affecting 500,000 people worldwide in 1916-1927 <sup>4</sup>. There have been no further epidemics of encephalitis lethargica since the 1920s, although sporadic cases have continued to be reported.</p><h4>Differential diagnosis</h4><p>General imaging differential considerations include:</p><ul>

References changed:

  • 1. Dale R, Church A, Surtees R et al. Encephalitis Lethargica Syndrome: 20 New Cases and Evidence of Basal Ganglia Autoimmunity. Brain. 2004;127(Pt 1):21-33. <a href="https://doi.org/10.1093/brain/awh008">doi:10.1093/brain/awh008</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/14570817">Pubmed</a>
  • 2. Morris S. Dickman, MD von Economo Encephalitis Arch Neurol. 2001; 58; 1696-1698
  • 3. Lopez-Alberola R, Georgiou M, Sfakianakis G, Singer C, Papapetropoulos S. Contemporary Encephalitis Lethargica: Phenotype, Laboratory Findings and Treatment Outcomes. J Neurol. 2009;256(3):396-404. <a href="https://doi.org/10.1007/s00415-009-0074-4">doi:10.1007/s00415-009-0074-4</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19412724">Pubmed</a>
  • 4. von Economo, C. Encephalitis lethargica. (1917) Wiener Klinische Wochenschrift. 30, 581–585.
  • 1. K. von Economo. Encepahlitis lethargica. Wiener klinische Wochenschrift, May 10, 1917, 30: 581-585. Die Encephalitis lethargica. Leipzig and Vienna, Franz Deuticke, 1918
  • 2. Dale RC, Church AJ, Surtees RA et-al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 2004;127 (1): 21-33. <a href="http://dx.doi.org/10.1093/brain/awh008">doi:10.1093/brain/awh008</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/14570817">Pubmed citation</a><span class="auto"></span>
  • 3. Morris S. Dickman, MD von Economo Encephalitis Arch Neurol. 2001; 58; 1696-1698
  • 4. Lopez-Alberola R, Georgiou M, Sfakianakis GN et-al. Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes. J. Neurol. 2009;256 (3): 396-404. <a href="http://dx.doi.org/10.1007/s00415-009-0074-4">doi:10.1007/s00415-009-0074-4</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/19412724">Pubmed citation</a><span class="auto"></span>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.